U.S. Multiomics Market Size & Outlook, 2026-2033

Name: U.S. Multiomics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The multiomics market in the United States is expected to reach a projected revenue of US$ 4,363.0 million by 2033. A compound annual growth rate of 15.6% is expected of the United States multiomics market from 2026 to 2033.

U.S. multiomics type outlook (Revenue, USD million, 2021-2033)
- Single-cell Multiomics
- Bulk Multiomics
U.S. multiomics platform outlook (Revenue, USD million, 2021-2033)
- Genomics
- Transcriptomics
- Proteomics
- Metabolomics
- Integrated Omics Platforms
U.S. multiomics product & service outlook (Revenue, USD million, 2021-2033)
- Services
- Product
  - Instruments
  - Consumables
  - Software
U.S. multiomics end use outlook (Revenue, USD million, 2021-2033)
- Pharmaceutical & Biotechnology Companies
- Others
- Academic & Research Institutes
U.S. multiomics application outlook (Revenue, USD million, 2021-2033)
- Immunology
- Cell Biology
- Oncology
- Neurology

U.S. Multiomics Market Size & Outlook, 2026-2033

Sign up - it's easy, and free!